Work

Reply LTE, Single time point tumour dosimetry assuming normal distribution of tumour kinetics

Year: 2022

Type: letter

Abstract: REPLY: We thank Dr. Kao for carefully reading our article ([ 1 ][1]) and for illustrating the value of single–time-point imaging in the practical implementation of patient-specific dosimetry for radiopharmaceutical therapy. We chose to focus on fundamental knowns and unknowns, particularly tumor

Source: Journal of Nuclear Medicine

DOI: 10.2967/jnumed.121.263717

Authors: George Sgouros, Yuni K. Dewaraja, Freddy Escorcia, Stephen A. Graves, Thomas A. Hope, Amir Iravani, Neeta Pandit-Taskar, Babak Saboury, Sara St. James, Pat B. Zanzonico

Institution: Johns Hopkins University

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4220892466

Cites: 3

Cited by: 3

Related to: 10